We want to find a safe and affordable test to diagnose AD even in those without symptoms, ultimately allowing us to treat AD earlier, before memory loss occurs.
Dr. Paul Aisen
Number of Americans living with AD.
1 in 4
65 year olds already have amyloid building up in their brain but do not yet have memory loss
Through a program we’ve created to build a trial-ready cohort, we have recruited 40,000 people interested in getting involved in clinical trials aimed at discovering treatments that will reduce the risk of AD. These people, all age 50 and older, have been screened and are members of the general population.
We want to invite 2,000 of these people for blood sample analysis every other year for the next 6 years. Our goal is to work with these people to find a blood test that accurately and reliably detects AD before any symptoms of memory loss occurs.
If found, this test will make it easier for people at risk to get involved in AD research and, ultimately, help us find a treatment or cure for AD faster.
This project is focused on raising funds for the first round of blood tests.
|Project Length||2 years|
|Goal||To identify a reliable blood test for Alzheimer's Disease before symptoms appear|
|Research Type||Clinical Trial|
Samlyn Capital, LLC
“Samlyn approaches philanthropy the same way we invest. We look for specific causes where we can participate in making a purposeful impact. We're excited to support groundbreaking Alzheimer’s research at USC’s ATRI in honor of Jacob's grandmother, Florence.”
Dedicated to Florence